Loading…

Bavarian Nordic received a USD 63 million order from BARDA to manufacture bulk product and 1 million freeze-dried doses of JYNNEOS smallpox/mpox vaccine. Bulk production is planned for 2025, with freeze-dried doses delivered in 2026.
“This award further strengthens the orders for the public preparedness business for 2025 and beyond and is yet another resounding endorsement of MVA-BN as the leading smallpox/mpox vaccine.”biospace.com
Summarized from public sources; check the original articles before acting on it.